SAN DIEGO – Accelrys, Inc. (NASDAQ:ACCL), a leading scientific enterprise R&D software and services company, today announced the Accelrys Modeling and Simulation Suite, a pillar of the new Accelrys Enterprise R&D Architecture. As a key element of the company’s strategy for optimizing the R&D value chain, the suite offers a unique platform approach to scientific modeling and simulation that reduces costs, enhances productivity and improves outcomes, quality and sustainability in R&D through the automation and expert use of predictive science.

“The use of predictive science is pushing deeper into the scientific value chain”

.The Accelrys Modeling and Simulation Suite includes Discovery Studio® software, Materials Studio software, the Pipeline Pilot™ Life Science and Materials Modeling and Simulation Collections, as well as the new QSAR Workbench, a packaged solution from Accelrys Professional Services. This suite offers scientific organizations engaged in pharmaceutical, chemical and materials R&D access to the broadest, deepest predictive science capabilities ranging across small molecules, biomolecules, chemicals and materials.

“The use of predictive science is pushing deeper into the scientific value chain,” said Dr. Frank Brown, vice president and chief science officer at Accelrys. “Although modeling and simulation has typically been viewed primarily as a research tool, more organizations are depending on it to reduce the number and cost of experiments and generate fresh insights in the development arena. Deploying modeling and simulation software on a unified, scalable platform like Pipeline Pilot can help organizations that are currently simulating less than ten percent of experiments increase that proportion significantly. This is one way to meet the critical performance, cost and innovation goals that define today’s increasingly information-driven R&D environment.”

The Accelrys QSAR Workbench, built on Pipeline Pilot and developed in collaboration with pharmaceutical company GlaxoSmithKline, automates and accelerates the development, validation and deployment of predictive Quantitative Structure-Activity Relationship (QSAR) models, improving decision making in R&D organizations. The unified Pipeline Pilot platform underlying the QSAR Workbench extends the productivity and reach of expert statisticians, enabling life science organizations to extend the range and impact of their computational experts. QSAR Workbench can also fuel innovation in materials science, enabling scientists working on polymers, surfactants and inorganic crystals to use statistical modeling in creating superior materials.

Modeling and Simulation within the Accelrys Enterprise R&D Architecture

The Accelrys Modeling and Simulation Suite of applications is a key pillar of the Accelrys Enterprise R&D Architecture with the flagship Discovery Studio and Materials Studio applications supported by the underpinning Pipeline Pilot platform. Pipeline Pilot’s built-in Chemistry, Biology and Materials Component Collections support the overall experimentation process while providing the depth and breadth of science required by state-of-the-art modeling and simulation, ultimately enabling organizations to bring better products to market with improved speed, efficiency, quality and sustainability.

Accelrys Discovery Studio provides comprehensive modeling and simulation capabilities for computational chemists, computational biologists and other scientists engaged in small molecule and biotherapeutics-based research.

Accelrys Materials Studio brings a comprehensive set of validated materials modeling and simulation methods to scientists working in chemicals and materials R&D, as well as drug development. Materials Studio offers user-friendly access to a complete range of scientific capabilities for modeling crystal structure and crystallization processes; for property prediction for molecules, polymers, catalysts and other materials; and for the development of structure-activity relationships.

To learn more about Accelrys QSAR Workbench and register for a free 30-day online trial, visit http://accelrys.com/services/qsar-workbench.html. Learn how the latest 3.0 release of Discovery Studio improves efficiency and collaboration in small molecule and biotherapeutics-based research by registering for a Discovery Studio webinar.

About Accelrys, Inc.

Accelrys (NASDAQ:ACCL), a leading scientific enterprise R&D software and services company, supports industries and organizations that rely on scientific innovation to differentiate themselves. Accelrys’ Enterprise Research & Development Architecture, built on the industry-leading Pipeline Pilot™ platform, provides a broad, flexible scientific solution optimized to integrate the diversity of science, experimental processes and information requirements across the research, development, process scale-up and early manufacturing phases of product development. By incorporating capabilities in applications for modeling and simulation, enterprise lab management, workflow definition and capture, data management and informatics, Accelrys enables scientific innovators to access, organize, analyze and share data in unprecedented ways, ultimately enhancing innovation, improving productivity and compliance, reducing costs and speeding time from lab to market.

Headquartered in San Diego, Calif., Accelrys has more than 1,300 customers in the life sciences, energy, chemical, aerospace, consumer products and industrial products industries and employs approximately 150 full-time PhD scientists. For more information about Accelrys, visit www.accelrys.com.